Early biologics linked with better Crohn’s outcomes

Early biologic treatment is associated with improved outcomes in patients with Crohn’s disease, according to study results.Ryan C. Ungaro, MD, of the Icahn School of Medicine at Mount Sinai, and colleagues wrote that biologics are often used later in treatment, after other therapies such as corticosteroids or thiopurines.“There is an increasing volume of evidence suggesting that early use of biologics can improve rates of remission and disease complications,” they wrote. “Despite these data, the rates of early adoption of biologic therapy are quite low in real-worldRead More

Share on facebook
Share on twitter
Share on linkedin